Corindus to Feature the CorPath® GRX System at the Transcatheter Cardiovascular Therapeutics: 2018 Conference

News

Submitted on Thu, 09/13/2018 - 09:00
PCI
WALTHAM, MASeptember 19, 2018 Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, will feature its CorPath®GRX System at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 Conference, September 21 – 25, in San Diego, CA. Corindus' CorPath GRX is the first FDA-cleared medical device for robotic-assisted vascular interventions. The company will showcase its revolutionary technology throughout the conference through live cases and presentations, during a Corindus-sponsored breakfast symposium, and at Booth 421.

On Sunday, September 23, 2018 from 6:30 a.m. – 8:00 a.m., Corindus' Cardiovascular Chief Medical Officer, Dr. J. Aaron Grantham of St. Luke's Hospital of Kansas City, will chair the breakfast symposium, "New Frontiers in Robotic Interventions: Current and Future Technology." The agenda will include the following topics:
 
  • "New Clinical Evidence in Robotic Interventions" presented by Lawrence Ang, M.D.
  • "Robotics for Complex PCI: A Case Series" presented by Manish A. Parikh, M.D.
  • "The 1st Remote PCI from 100 Miles Away" presented by Ryan Madder, M.D.
  • "Building the Next Generation Robot" presented by Mitchell Krucoff, M.D.

Space for the breakfast symposium is limited; please register at www.tctconference.com/satelliteprograms.

"I am pleased to chair this educational program with an esteemed group of interventionalists to highlight the current and future capabilities of vascular robotics. There has been tremendous progress made in the development of our robotic platform, including procedural automation and remote technology, which we believe will have the power to change the treatment paradigm and increase patient access to care," said J. Aaron Grantham, M.D., Cardiovascular Chief Medical Officer of Corindus.

The CorPath GRX System will be on display at Corindus' Booth 421. Attendees will have the opportunity to be among the first to experience future procedural automation techniques and compete with their peers in a wiring challenge. To schedule a hands-on demonstration of vascular robotics with an advanced simulator, please visit www.corindus.com/TCT2018.

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For 30 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. This symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath® System is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. CorPath GRX is the second generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. For additional information, visit www.corindus.com, and follow @CorindusInc.

# # #
Media Contact:
Lisa Murray
T: 978-750-0333 ext. 2
Investor Relations Contact:
Lisa Wilson
In-Site Communications, Inc.
T: 917-543-9932